DE
Therapeutic Areas
PainReform Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PRF-110 | Post-operative pain relief following bunionectomy | Phase 3 |
Leadership Team at PainReform
IH
Ilan Hadar
Chief Executive Officer and Director
DE
Dr. Eli Hazum
Chairman of the Board
DY
Dr. Yossi Ben-David
Chief Financial Officer
DY
Dr. Yonatan Malach
Vice President, Clinical Development
DY
Dr. Yohanan Goldschmidt
Director
DY
Dr. Yael Cohen
Director
DY
Dr. Yael Weiss
Director
DY
Dr. Yaron Daniely
Former Director